Grupo de Investigación de Lípidos y Señalización Celular
![Foto de Grupo de Investigación de Lípidos y Señalización Celular](/img/grupo.png)
![Foto de French Institute of Health and Medical Research](/img/noimage_org.png)
French Institute of Health and Medical Research
París, FranciaPublications in collaboration with researchers from French Institute of Health and Medical Research (6)
2018
-
Low-dose statin treatment increases prostate cancer aggressiveness
Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504
2007
-
Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors
Endocrinology, Vol. 148, Núm. 9, pp. 4136-4146
2004
-
Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms
European Journal of Pharmacology, Vol. 501, Núm. 1-3, pp. 59-69
2002
-
Pharmacological characterization of F-180: A selective human V 1a vasopressin receptor agonist of high affinity
British Journal of Pharmacology, Vol. 135, Núm. 7, pp. 1828-1836
1995
-
Vasopressin stimulates steroid secretion in human adrenal glands: Comparison with angiotensin-II effect
Endocrinology, Vol. 136, Núm. 3, pp. 1285-1295
1991
-
Dual effects of ATP on phosphatidylinositol breakdown in rat hepatocyte membranes
Cellular Signalling, Vol. 3, Núm. 6, pp. 577-585